Sun Pharma Advanced Research Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Anilkumar Raghavan
Chief executive officer
₹69.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.6yrs |
| CEO ownership | n/a |
| Management average tenure | 1.2yrs |
| Board average tenure | 7.5yrs |
Recent management updates
Recent updates
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans
Jan 17
Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't
Nov 14Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?
Sep 05Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation
Jun 27Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?
Nov 23If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%
Feb 08
Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?
Dec 14CEO
Anilkumar Raghavan (56 yo)
10.6yrs
Tenure
₹69,608,000
Compensation
Mr. Anilkumar Raghavan has been the Chief Executive Officer of Sun Pharma Advanced Research Company Limited since April 24, 2014. Mr. Raghavan is a senior pharmaceutical services executive with significant...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 10.6yrs | ₹69.61m | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | less than a year | no data | no data | |
| Senior General Manager of Business Development | no data | no data | no data | |
| Company Secretary & Compliance Officer | 1.2yrs | no data | no data | |
| Chief Human Resource Officer | 4.8yrs | no data | no data | |
| Head Clinical Development | less than a year | no data | no data | |
| Chief Innovation Officer | no data | no data | no data | |
| Head of Drug Delivery Systems | no data | no data | no data | |
| Head of Preclinical Development | 5.6yrs | no data | no data | |
| Global Head of Drug Discovery & Preclinical Development | 1.7yrs | no data | no data | |
| VP & Head Operations Management | less than a year | no data | no data |
1.2yrs
Average Tenure
Experienced Management: SPARC's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 18.7yrs | ₹390.00k | 19.06% ₹ 12.9b | |
| Independent Director | 4.4yrs | ₹630.00k | no data | |
| Independent Director | 10.1yrs | ₹660.00k | no data | |
| Non-Executive Non-Independent Director | 17.4yrs | ₹300.00k | 0.011% ₹ 7.5m | |
| Additional Non-Executive Non-Independent Director | less than a year | no data | no data | |
| Independent Director | 7.5yrs | ₹630.00k | no data | |
| Member of Advisory Board | 3.9yrs | ₹570.00k | no data |
7.5yrs
Average Tenure
66yo
Average Age
Experienced Board: SPARC's board of directors are considered experienced (7.5 years average tenure).